Introduction similar to those of the staggerer mouse. The staggerer mouse represents a spontaneously arising mutation that Elevation of intracellular Ca 2ϩ plays a prominent role in has been studied as an animal model of ataxia (Sidman a broad array of cellular functions including the activation et al., 1962) . In addition to the neurological defects, these of transcription and regulation of cellular processes such animals also display immunological and reproductive as the cell cycle and apoptosis (Means, 1995) . The Ca 2ϩ deficiencies (Trenkner and Hoffmann, 1986 ; Guastavino signal is mediated principally by calmodulin (CaM), which and Larsson, 1992). Hamilton et al. (1996) positionally serves as the cell's primary Ca 2ϩ receptor in both the cloned the staggerer mutation and demonstrated that it cytoplasm and nucleus. Ca 2ϩ /CaM activates many prevents translation of the ligand-binding domain (LBD) enzymes including protein kinases and phosphatases, of the retinoic acid receptor-related orphan receptor α adenylyl cyclases and cyclic nucleotide phosphodiesterases (RORα). RORα is a member of the thyroid/steroid super- (Means, 1995) . Within this group of signaling molecules, family of nuclear receptors and is expressed in the Purkinje significant emphasis has been placed upon the CaMcells of the cerebellum as well as in lymphoid and dependent protein kinases (CaMKs). Three CaMKs, I, II reproductive tissues Hamilton et al., and IV (CaMKI, CaMKII and CaMKIV, respectively) , are 1996; Steinmayr et al., 1998) . RORα binds DNA as a multifunctional protein Ser/Thr kinases, each of which monomer and has been shown to drive transcription phosphorylate a variety of substrates in vitro and in vivo constitutively from its cognate response element (Giguère (for a review, see Anderson and Kane, 1998) . While et al., 1994 While et al., , 1995 . As this transactivation occurs in the CaMKI and CaMKII are widely expressed throughout the absence of any known ligand, RORα is classified as an body, CaMKIV expression is relatively limited to the orphan receptor. Recently, two independent laboratory brain, T-lymphocytes and post-meiotic male germ cells (Ohmstede et al., 1989; Frangakis et al., 1991; Means groups have disrupted the RORα gene and recapitulated the staggerer phenotype in both sets of mice, demonstrating that functional disruption of the RORα gene is the bona fide target of the staggerer mutation (Dussault et al., 1998; Steinmayr et al., 1998) . Given the ability of CaMKIV to activate transcription factors such as CREB, the overlapping tissue expression patterns of CaMKIV and RORα and the similar phenotypes of the CaMKIV-and RORα-deficient animal models, we tested the ability of CaMKIV to potentiate the transcriptional activity of RORα. We report here that RORα is a Ca 2ϩ -responsive transcription factor and that RORα, as well as several other orphan receptors, can be activated potently by CaMKIV. Transactivation of RORα is dependent upon its LBD, although the receptor itself is not the target of the kinase. We have identified a class of peptides containing an LXXLL motif that specifically interacts with the LBD of RORα in a CaMKIV-dependent manner. These peptides can serve as potent antagonists of RORα-and other orphan receptor-mediated transcription in both the absence and presence of CaMKIV. Our findings suggest a novel paradigm governing the transactivation of a select group of orphan receptors, in which biological stimuli that mobilize Ca 2ϩ signaling cascades can markedly increase orphan receptor-mediated transcription via the activation of CaMKIV. Such a mechanism provides an alternative means by which these orphan receptors, when co-expressed Based upon the similarity of phenotypes seen in staggerer or both ionomycin and KN-93. Cells were stimulated for an additional 24 h, harvested and the luciferase activity reported as and CaMKIV-deficient animals, we asked whether corrected relative light units.
CaMKIV could increase transcription mediated by RORα. Thus, we transiently transfected the human keratinocyte cell line HaCaT with an expression vector for human Rous sarcoma virus (RSV) and SV40 promoters and compared them with CMV-driven RORα in the absence RORα and its cognate luciferase-based reporter containing three copies of a consensus RORα response element in and presence of CaMKIV 1-317. Each RORα expression vector displayed statistically indistinguishable constitutive front of the thymidine kinase minimal promoter [ROR-E(3)TKluc]. As reported previously for this receptor, activity and each was significantly induced by CaMKIV 1-317 (data not shown), suggesting that the activation of RORα displays constitutive and ligand-independent transcriptional activity ( Figure 1A , open bar) (Giguère transcription is not due to an indirect effect of the kinase on the RORα expression vector. Finally, CaMKIVet al., 1994) .
To determine if CaMKIV could potentiate this activity dependent activation of RORα was also found to occur in other cell lines including the human T-cell line Jurkat further, an expression vector encoding Ca 2ϩ /CaM-independent CaMKIV (CaMKIV 1-317) was co-transfected and the rat pituitary cell line GH3 (data not shown). In each instance, marked activation of RORα occurred in with the RORα expression vector. Quite surprisingly, CaMKIV activated transcription from RORE(3)TKluc an the presence of Ca 2ϩ /CaM-independent CaMKIV, indicating that this effect was not cell line specific. additional 20-to 30-fold over the activity of RORα alone ( Figure 1A , black bar). Co-transfection of a catalytically While it was clear that RORα could be activated by Ca 2ϩ /CaM-independent CaMKIV, we wanted to determine inactive expression vector of CaMKIV (K75E CaMKIV 1-317) failed to produce any additional activation above if RORα activity could be modulated by Ca 2ϩ signaling. Therefore, HaCaT cells were transfected with RORα and that of RORα's constitutive activity, indicating that CaMKIV protein kinase activity was required for RORα subsequently were stimulated with the Ca 2ϩ -elevating agent ionomycin. Ionomycin treatment had a negligible activation ( Figure 1A , striped bar) while co-transfection of CaMKIV 1-317 modestly activated reporter alone effect upon reporter alone ( Figure 1B , left hand side). However, treatment with ionomycin potently activated (Figure1A, speckled bar). Because the RORα expression vector used in these experiments was driven by the RORα. This activation resulted in nearly a 12-fold activation of RORα in the presence of Ca 2ϩ versus its activity cytomegalovirus (CMV) promoter, and because this promoter has recently been shown to be Ca 2ϩ sensitive, we in the presence of dimethylsulfoxide (DMSO) ( Figure 1B , right hand side, open versus stippled bar). produced constructs derived from the Ca 2ϩ -insensitive These results demonstrate a clear CaM kinase specificity for RORα activation, with CaMKIV and CaMKI acting to stimulate RORα-mediated transcription while CaMKIIα fails to do so.
Activation of transcription by CaMKIV is selective for orphan nuclear receptors
Next we examined if activation of RORα-mediated transcription was specific for RORα or was a property shared by several classes of nuclear receptors. We therefore surveyed a cohort of nuclear receptors for their ability to from this reporter Schräder et al., and catalytically inactive CaMKIIα (K42M CaMKIIα 1-290). Cells 1996). In addition to RORα1, the receptors tested included were maintained in culture for 36 h, harvested and the luciferase an N-terminal splice variant of RORα1 termed RORα2, activity reported as corrected relative light units. a separate ROR gene family member termed RORγ and an unrelated orphan receptor COUP-TFI. As seen in Figure 3A (left hand side), all of these receptors display HaCaT cells express endogenous CaMKIV based upon their expression of CaMKIV mRNA as detected via RTsome ligand-independent, constitutive activity, as has been reported previously Medvedev et al., PCR and Northern analysis (C.D. Kane and A.R.Means, unpublished data) . In addition to CaMKIV, it is possible 1996; Schräder et al., 1996) . Co-transfection of CaMKIV 1-317 resulted in marked activation of all the orphan that the ubiquitously expressed CaM kinases I and II as well as other CaM-dependent enzymes are also expressed receptors tested ( Figure 3A , right hand side). The fold activation for the ROR orphan receptors was generally in in these cells. In order to identify a role for a CaM kinase in RORα activation, KN-93, a selective inhibitor of the range of 20-to 40-fold induction, while that for COUP-TF1 was in the 7-to 10-fold range. CaMKI, II and IV, was added concomitantly with ionomycin to cells transfected with RORα. While KN-93 did Next we tested the ability of CaMKIV to potentiate the activity of two prototypical nuclear receptors, the thyroid not adversely effect the constitutive activity of RORα ( Figure 1B , black bar), the drug potently repressed the hormone receptor (TRα) and the estrogen receptor (ERα). Transient transfection of Jurkat cells with an expression ability of ionomycin to activate RORα ( Figure 1B , striped bar). These results show that a CaM kinase inhibitor can vector for TRα and treatment with 150 nM T3 resulted in a large T3-dependent induction of TRα-mediated tranblock Ca 2ϩ -dependent activation of RORα, suggesting that activation of RORα-mediated transcription by Ca 2ϩ scription ( Figure 3B , open bars). If CaMKIV 1-317 was co-transfected with TRα, no potentiation of TRα-mediated is occurring via activation of a CaM kinase.
transcription occurred in either the absence or the presence of T3 ( Figure 3B , black bars). Likewise, co-transfection
CaMKIV and I, but not II, can activate RORα
In order to determine which members of the CaM kinase with K75E CaMKIV 1-317 also had no significant effects upon TRα-mediated transcription ( Figure 3B , striped bars) family could activate RORα transcription, HaCaT cells were transiently transfected with expression vectors encodSimilar experiments were performed using ERα to test for transcriptional potentiation in the presence of CaMKIV. ing Ca 2ϩ /CaM-independent CaM kinase I, II or IV. As previously seen in Figure 1 , CaMKIV potently activated As seen in Figure 3C (left side), the presence of CaMKIV 1-317 did not potentiate the ligand-independent activity RORα-mediated transcription 20-to 30-fold more than that seen by RORα alone (Figure 2 , black versus open bar).
of ERα. CaMKIV also failed to provide any additional potentiation of the 17β-estradiol-dependent activity of Activation was also obtained with Ca 2ϩ /CaM-independent CaMKI (Figure 2 , shaded bar). The different efficacies of ERα ( Figure 3C , right side). These findings demonstrate that the presence of CaMKIV does not change either the RORα activation in response to CaMKIV and CaMKI may reflect differences in the relative expression levels of ligand-dependent or ligand-independent transactivation of the thyroid or estrogen nuclear receptors and that the the transfected kinase cDNA constructs in HaCaT cells. In contrast, Ca 2ϩ /CaM-independent CaMKIIα failed to ability of CaMKIV to activate transcription seems to be limited to a distinct group of orphan receptors. demonstrate any activation and actually seemed to repress RORα's constitutive activity ( Figure 2 , wavy bar). Indeed, in contrast to CaMKIV and CaMKI, CaMKII has been Phosphorylation of the N-terminus of RORα is not required for CaMKIV-dependent transactivation shown potently to repress transcriptional activation by several transcription factors (Matthews et al., 1994;  Previous studies by Giguère et al. (1994 Giguère et al. ( , 1995 McBroom et al., 1995) the CaMKIV-activated state. However, the overall fold induction of both wild-type and S49/58E RORα by CaMKIV was similar (23-fold versus 30-fold, respectively). This observation was corroborated by an additional experiment in which an N-terminal truncation mutant (Δ23-74 RORα) also displayed robust activation after co-transfection with CaMKIV (data not shown). These experiments suggest that the putative CaMKIV phosphorylation sites found within the N-terminal domain of RORα are not required for the CaMKIV-dependent activation of RORα-mediated transcription.
Enhancement of RORα-dependent transactivation by CaMKIV is mediated through the LBD
While there is significant variability in the primary amino acid sequences of the LBDs of the various members of the nuclear/steroid receptor superfamily, crystallographic analysis of these domains from PR, ERα, PPARγ, RXRα and TRα have shown that the principal folding features are conserved (Wurtz et al., 1996) . Structural and mutagenesis studies of liganded receptors have suggested a key role (Oñate et al., 1995; Hong et al., 1996;  relative light units. (B) Jurkat cells were transfected with 12 μg of TREpal(2)luc reporter and 4 μg of TRα expression vector in the Wurtz et al., 1996; Torchia et al., 1997) Harding et al., 1997) . In order to address if 100 nM 17β-estradiol for 24 h, harvested and the luciferase activity the LBD of RORα is sufficient to mediate CaMKIVreported as corrected relative light units. dependent activation of transcription, the LBD of RORα was fused in-frame to the DNA-binding domain (DBD) of the yeast transcription factor Gal4 (Gal4:RORLBD). within this regulatory domain and match the consensus recognition motifs for CaMKIV  This construct or Gal4DBD alone was co-transfected into GH3 cells with a 5ϫ Gal4UAS/TATA/luciferase reporter White et al., 1998) . In order to test if these residues are required for CaMKIV-dependent activation of RORα, a in the absence or presence of CaMKIV 1-317. As seen in Figure 5 , Gal4:RORLBD exhibits constitutive transcripdouble point mutant, S49E/S58E RORα (S49/58E RORα), was used in the transient transfection assay. As shown in tional activity and can be activated upon co-transfection with CaMKIV, while the Gal4DBD is transcriptionally Figure 4 (left hand side), both the wild-type and S49/58E RORα have identical constitutive activities on the reporter. silent under all conditions tested. These results demonstrate that the effects of CaMKIV on full-length RORα can be Co-transfection of CaMKIV 1-317 resulted in potent activation of both receptors (Figure 4 , right hand side).
recapitulated with an RORLBD chimera. Thus, the LBD of RORα is sufficient for mediating the CaMKIV-dependent The overall transcriptional activity of S49/58E RORα was slightly greater than that of the wild-type receptor in activation of transcription. 
SDS-PAGE. Coomassie staining indicated that the peptide was present
As shown by the autoradiogram in Figure 6A (upper in equal amounts for all reactions (data not shown).
panel), GST:RORLBD was not phosphorylated in the presence of either kinase reaction buffer or CaMKI. 'NR-box ' (Heery et al., 1997; Torchia et al., 1997) . In CaMKI can be activated further by the addition of an attempt to identify LXXLL-containing peptides that CaMKKB, which phosphorylates Thr177 of CaMKI. This specifically interact with liganded ERα, Chang et al. activation loop phosphorylation significantly enhances the (1999) used a combinatorial phage display approach and kinetics of CaMKI substrate phosphorylation and increases discovered three classes (class I, II and III) of small, its specific activity 25-fold (Haribabu et al., 1995) . The 19 amino acid peptides that specifically bound ERα in an addition of CaMKKB to CaMKI resulted in the phosagonist-dependent manner. Representative members of phorylation of CaMKI, yet CaMKI failed to recognize each of these classes as well as LXXLL-containing pep-GST:RORLBD as a substrate ( Figure 6A, upper panel) .
tides from the coactivators P300, GRIP1 and SRC1 were Likewise, CaMKKB alone also failed to phosphorylate tested in the context of the mammalian two-hybrid assay GST:RORLBD. Both enzymes were shown to be active, in order to identify peptides that could interact with the as control reactions run in parallel with a peptide corres-LBD of RORα in either the absence or presence of ponding to the N-terminal 1-117 amino acids of P300 CaMKIV. A series of peptides containing a central LXXLL (1-117:P300) demonstrated that CaMKI was active on its motif were expressed as fusion proteins with the Gal4DBD. own and that addition of CaMKKB resulted in a marked
The entire RORα LBD was expressed as a fusion protein increase in CaMKI activity ( Figure 6B ). Coomassie stainwith the VP16 activation domain (VP16:RORLBD) and ing of the fractionated kinase reactions indicated that these two plasmids were transiently transfected into HaCaT GST:RORLBD was present in equal amounts for all cells in the absence or presence of CaMKIV 1-317. A reaction conditions ( Figure 6A , bottom panel). These single class of VP16:RORLBD-interacting peptides was results demonstrate that the LBD of RORα is not an in vitro identified. As seen in Figure 7A (left hand side), the substrate for CaMKI and suggest that the mechanism peptides fused to Gal4DBD did not support basal transcripof CaM kinase activation of RORα is not via direct tion by themselves. When co-transfected in the presence phosphorylation of RORα itself. This is supported by the of VP16:RORLBD, two members of the class II peptides failure of either CaMKI or CaMKIV to phosphorylate showed weak interaction ( Figure 7A , D47 and C33, middle in vitro transcribed and translated full-length RORα (data section). Surprisingly, co-transfection of CaMKIV 1-317 not shown).
resulted in a robust increase in the interaction between class II peptides D47/C33 and VP16:RORLBD that was Detection of RORLBD-interacting peptides not seen with the non-interacting class III peptide F6 The nuclear receptor coactivators have been found to contain a signature LXXLL motif, also referred to as an ( Figure 7A , right hand side). The class II peptides D47 the entire hormone-binding domain (HBD) of ERα (VP16:ERαHBD). Chang et al. (1999) have shown that the peptide-binding specificity of ERα is the converse of what is observed for RORα, i.e. β-estradiol-bound VP16:ERαHBD binds weakly to D47 and strongly to F6. This result is recapitulated in Figure 7B (left hand side) in which agonist-bound VP16:ERαHBD interacts weakly with D47 and strongly with F6, whereas no interactions occur in the absence of ligand. Co-transfection with CaMKIV 1-317 fails to increase the interactions between VP16:ERαHBD and D47, while causing a modest (Ͻ1-fold) increase of interaction for F6 ( Figure 7B , right hand side). The failure of CaMKIV to cause a significant increase in the interaction between the peptides and the HBD of ERα is consistent with the selectivity seen for the activation of distinct classes of nuclear receptors by CaMKIV.
Class II LXXLL-containing peptides can disrupt RORα-mediated transcription
It has been suggested that LXXLL-containing peptides interact with the AF-2 region of nuclear receptors by mimicking interactions used by full-length coactivators (Heery et al., 1997; Torchia et al., 1997; Nolte et al., 1998; Chang et al., 1999) . Based on these data, we thought it likely that the class II peptides should also interact with the AF-2 region of RORα and that, if so, they should act as dominant-negative inhibitors of RORα-mediated transcription. In order to investigate this hypothesis, RORα was co-transfected with CaMKIV 1-317 in HaCaT cells in the presence of increasing input DNA encoding either the RORα-interacting peptide D47 or the non-interacting peptide F6. Luciferase activity was plotted as the percentage of maximal RORα-dependent activity seen in the the interaction of RORα with a putative endogenous coactivator. In order to observe if D47-dependent repression of and C33 were the only fusion proteins that displayed basal and CaMKIV-dependent interaction. Other peptides RORα was unique to this receptor or if it was common to other orphan receptors, a similar repression experiment containing LXXLL motifs from P300, GRIP-1 and SRC1 failed to interact with the RORLBD in either the absence was carried out with the orphan nuclear receptors RORγ and COUP-TFI. As seen in Figure 8B , D47 was a or presence of CaMKIV (data not shown). These results suggest that the LBD of RORα is necessary and sufficient potent inhibitor of CaMKIV-dependent RORγ-mediated transcription and also repressed COUP-TFI, but to a lesser for interaction with peptides containing the LXXLL nuclear receptor-interacting motif and that CaMKIV can extent (filled versus open circles). While RORγ was repressed to~25% of its maximal activity and to an extent increase these interactions in the context of a mammalian cell. similar to RORα, COUP-TFI was repressed to only 60% of its maximal activity. This may be due to the fact that In order to strengthen the correlation between CaMKIV activity and the modulation of orphan receptor activity, on the RORE(3)TKluc reporter, RORα and RORγ bind as monomers and may be repressed efficiently by a single we assessed the peptide-binding activities of ERα in the context of the mammalian two-hybrid assay in the absence copy of D47. In contrast, COUP-TFI will bind as either a homodimer or a heterodimer with RXR (Cooney et al., or presence of CaMKIV. Recalling that ERα is unresponsive to CaMKIV (Figure 3C ), we obtained an expression 1992) and, therefore, may not be repressed as efficiently by a single copy of D47. Collectively, these results suggest vector containing the VP16 activation domain fused to stimuli would be predicted to be significant activators of RORE-responsive genes. The identification of ROREcontaining genes in tissues expressing CaMKIV will be a prerequisite for testing this hypothesis in vivo.
Covalent modification via phosphorylation is known to be a potent mechanism for activation of transcription factors such as CREB and the CREB family members (Gonzalez and Montminy, 1989; Sun et al., 1996) . In stimulated cells, CaMKIV and other CREB kinases are known to phosphorylate CREB on Ser133. This phosphorylation event is required for the recruitment of the coactivator CBP, which nucleates a multiprotein complex that ultimately produces a large increase of CREBmediated transcription (Chrivia et al., 1993) . Stimulation of nuclear hormone receptors occurs through the introduction and binding of their cognate ligands. Ligand binding dissociates bound co-repressor molecules, which allows recruitment of coactivator molecules that support transcription. Like CREB, several of the nuclear receptors including PR, ERα, ERβ and PPARγ undergo phosphorylation (for a review, see Weigel and Zhang, 1998) . The receptors are often multiply phosphorylated on serine and threonine residues by several different kinases including PKA and the MAP kinases (Aronica and Katzenellenbogen, 1993; Bunone et al., 1996; Weigel and Zhang, 1998) . In general, nuclear receptor phosphorylation affects DNA and/or ligand binding, resulting in either modest potentiation or repression of transcription (Aronica and Katzenellenbogen, Hu et al., 1996; Takimoto et al., 1996) . Our studies suggesting that the target of CaM kinase activity is not RORα itself.
The naturally occurring staggerer mutation and deletion that the ability of D47 to repress RORα, RORγ and COUP-TFI is a common property, and imply that D47 is analysis of RORα, as well as our own work ( Figure 5 ), demonstrates that the AF-2 domain of the RORα LBD is competing for a specific coactivator that is present in HaCaT cells and required for the transcriptional activity required for transcriptional activity. In the context of the mammalian two-hybrid assay performed in HaCaT cells, of these orphan receptors.
the LBD of RORα is sufficient for interaction with specific LXXLL-containing peptides. Co-transfection of CaMKIV Discussion increases this interaction significantly, demonstrating that the LBD is a sufficient platform for supporting CaMKIVThe term orphan receptor has been developed to describe those nuclear receptors for which there are no known dependent induction of transcription. Direct phosphorylation of the interacting LXXLL peptides by CaMKIV is ligands. Unlike the traditional thyroid/steroid class of nuclear receptors that require specific ligands to support not possible, as they do not contain the RXXS substrate recognition motif required for substrates of CaMKIV transcription, the orphan receptors display constitutive activity that is thought to be ligand independent. Our (Table I) . This finding strongly suggests that CaMKIV is phosphorylating and activating another protein(s) that is experiments have indicated that an established signaling pathway can potently activate orphan receptor-mediated serving as a bridge or scaffold between the LBD and the interacting class II peptides. transcription in a previously undescribed manner. We have shown that RORα is a Ca 2ϩ -responsive transcription factor Potential candidates for the 'bridge' between RORα and the class II RORα-interacting peptides are the cowhose constitutive activity is significantly enhanced by Ca 2ϩ influx and that this increase of activity requires CaM integrator molecules CBP and/or P300, which act as transcriptional adaptors for a plethora of transcription kinase activity. In this respect, RORα joins CREB as a facilitator of Ca 2ϩ -induced gene expression. Many factors (Chrivia et al., 1993; Eckner et al., 1994) . The adenoviral oncoprotein E1A can bind to and inhibit CBP/ biological stimuli including hormones, growth factors and T-cell receptor engagement induce Ca 2ϩ signals and P300 function (Arany et al., 1995) . Therefore, cotransfection of an expression vector encoding E1A subsequent activation of transcription (Means, 1995) . In those tissues that co-express RORα and CaMKIV, such commonly is used to disrupt CBP/P300-dependent of the ability of its LBD to interact stably with the peptides could be used as peptide antagonists of orphan receptor-mediated transcription. As such, these peptides could be powerful tools in the study of orphan receptortranscription. Indeed, co-transfection of E1A represses Ͼ95% of the CaMKIV-dependent activation of RORα, related biology or as possible therapeutic agents in cases of orphan receptor-mediated disease. implicating CBP/P300 in RORα-mediated transcription (data not shown). However, in contrast to a recent report
In recent years, the physiological ligands for several former orphan receptors have been discovered and found which described the interaction between the N-terminus of P300 and RORα in JEG-3 cells (Lau et al., 1999) , to be metabolites of lipophilic and/or steroid molecules. These include 9-cis retinoic acid for RXR (Heyman et al., mammalian two-hybrid analysis using the LXXLL domain of P300 (amino acids 74-92) or larger fragments of P300 1992), polyunsaturated lipids and their metabolites for PPARs (Göttlicher et al., 1992) , and, most recently, (amino acids 1-117 or 1-595) failed to interact with VP16:RORLBD in HaCaT cells (Table I and data not chenodeoxycholic acid and other bile acids for the farnesyl X receptor (Makishima et al., 1999; Parks et al., 1999) . shown). Clearly, in HaCaT cells, CBP/P300 is required for RORα function but associates with RORα indirectly, It remains probable that several of the current orphan receptors will eventually be shown to require ligands in suggesting a supporting role for this co-integrator in RORα-mediated transcription.
order to stimulate transcription. In this regard, an alternative explanation concerning the ability of CaMKIV to Analysis of the class II peptides that interact with RORα's LBD has allowed the creation of an RORα activate RORα that has not been addressed in our studies is the possibility that activation of CaMKIV results in interaction motif where the primary determinants appear to be HVXXHPLLØXLL ( Table I ). Note that the coactivators creation of the physiological ligand of RORα. Such a process could be due to the ability of CaMKIV to that failed to interact with RORα's LBD in HaCaT cells (P300, SRC-1 and GRIP1) do not contain a proline residue covalently modify and therefore regulate the activity of a biosynthetic enzyme involved in either the production or at the -2 position relative to the LXXLL sequence. The ability of the class II peptides to interact with RORα's destruction of a currently unidentified, naturally occurring ligand for the orphan receptors examined here. Confirma-LBD would imply that a proline at the -2 position is a key determinant of coactivator-orphan receptor binding tion of these ideas awaits the time that this currently hypothetical ligand has been isolated and fully characterspecificity. Pattern Hit Initiated (PHI)-BLAST searches of the sequence database using this consensus and the peptide ized as a bona fide ligand of RORα. Based upon this work, we can propose at least two possible models for sequences of C33 and D47 reveal that there are currently no statistically significant identities between the peptides activation of RORα-mediated transcription by CaMKIV. In the first model, CaMKIV mediates its positive effects and the deposited sequences. This raises the exciting possibility that a novel, 'class II-like' coactivator molecule on transcription through the covalent modification of coactivator molecules such as the putative 'class IIexists for the orphan receptors that has yet to be identified. Such a factor would be expected to be expressed in like' coactivator and/or CBP/P300. The second model of CaMKIV activation could occur at the level of the LBD multiple tissues and to interact stably and constitutively with RORα, based upon the ability of RORα to drive of RORα in a manner reminiscent of the traditional nuclear receptors. In this scenario, cellular stimulation and transcription in the absence of CaMKIV in at least three different cell lineages (epidermal, lymphoid and neuronal;
CaMKIV activation would modulate the activity of a biosynthetic enzyme which modifies or produces a lipodata not shown). There is current biological precedence for a nuclear receptor that is constitutively active in the philic molecule that serves as a physiological ligand of RORα. Ligand binding to RORα would nucleate a comabsence of naturally occurring ligands. The orphan receptor CAR-β (constitutive androstane receptor-β) has been plex between the receptor, the 'class II-like coactivator' and a co-integrator molecule such as CBP/P300, as is shown to exhibit ligand-independent transcription by virtue
